Oct 7 (Reuters) - Codiak BioSciences Inc CDAK.O :
* CODIAK BIOSCIENCES, INC SEES IPO OF UP TO 5.5 MILLION
SHARES OF
COMMON STOCK TO BE PRICED BETWEEN $14.00 AND $16.00 PER SHARE -
SEC FILING
* CODIAK BIOSCIENCES INC SAYS INTENDS TO USE ABOUT $24.8
MILLION
OF IPO PROCEEDS FOR ADVANCEMENT OF EXOSTING, INCLUDING CONDUCT
OF PHASE 1/2 CLINICAL TRIAL
* CODIAK BIOSCIENCES INC SAYS INTENDS TO USE ABOUT $10.1
MILLION
OF IPO PROCEEDS FOR ADVANCEMENT OF EXOIL-12, INCLUDING CONDUCT
OF PHASE 1 CLINICAL TRIAL
* CODIAK BIOSCIENCES INC SAYS INTENDS TO USE ABOUT $34.3
MILLION
OF IPO PROCEEDS FOR THE EXPANSION OUR ENGEX PLATFORM
Source text: urn:newsml:reuters.com:*:nFWN2GX11Q
Further company coverage: CDAK.O
((Reuters.Briefs@thomsonreuters.com;))